Tom Donovan brings to Ten Bridge experience from multiple assignments in London, Australia and New Zealand. His most recent role was as director of communications for Nexvet Biopharma, a NASDAQ-listed biotechnology company that was acquired by Zoetis in 2017. Leading to acquisition, Tom worked with the company's executive team across all aspects of corporate and investor communications, from its early funding rounds, re-incorporation in Ireland, global operational expansion and IPO. Prior to this, Tom worked in a variety of communications consultant or policy roles to private biotech companies and government innovation teams in Australia, including development of the Global Health Melbourne Plan. Prior to this, Tom worked in investor and public relations consultancy roles with ASX-listed biotechnology companies, and as a junior business journalist in New Zealand. Tom has a bachelor's degree in biomedical science and a master's degree (1st class honors) in bioscience enterprise, both from the University of Auckland.